8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Apr 20, 2016)

Filed April 20, 2016For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on April 20, 2016, to report its first-quarter 2016 financial results. The filing includes a press release detailing the company's performance and financial condition. A key aspect of the report is Abbott's use of non-GAAP financial measures, which management believes provide a clearer view of ongoing business performance by excluding unusual or unpredictable items. Investors should note that these non-GAAP measures adjust for factors such as foreign exchange impacts (specifically mentioning Venezuela), cost reduction initiatives, transaction costs, and tax-related adjustments. While Abbott's management finds these measures useful for internal assessment and for investor understanding, the company advises investors to consider them alongside, and not as a substitute for, their GAAP-reported results.

Key Highlights

  • 1Abbott Laboratories reported its Q1 2016 financial results via an 8-K filing.
  • 2The report includes a press release detailing operational results and financial condition.
  • 3Abbott utilizes non-GAAP financial measures to present performance.
  • 4Non-GAAP measures are adjusted for items like foreign exchange losses (Venezuela), cost reductions, transaction costs, and tax adjustments.
  • 5The company believes these non-GAAP measures offer better insight into ongoing business performance.
  • 6Management uses these non-GAAP measures for internal performance monitoring.
  • 7Investors are cautioned to consider non-GAAP measures in conjunction with GAAP results.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce and provide the details of Abbott Laboratories' financial results for the first quarter of 2016.

Non-GAAP financial measures are financial metrics that exclude certain items from the standard GAAP (Generally Accepted Accounting Principles) calculations. Abbott uses them to provide investors with a clearer view of their core business performance by excluding items that are considered unusual, unpredictable, or not part of ongoing operations, such as foreign exchange fluctuations, restructuring costs, and specific tax items.

The filing specifically mentions that non-GAAP measures exclude items like foreign exchange losses related to Venezuela, cost reduction initiatives, transaction-related costs, and resolutions of tax uncertainties or adjustments from prior years. Intangible amortization expense is also excluded.

No, Abbott advises investors to consider these non-GAAP financial measures in addition to, and not as a substitute for, the financial measures prepared in accordance with GAAP. GAAP results provide the standardized, audited financial picture, while non-GAAP measures offer a different perspective on operational performance.